Ketamine Therapy
Exploring another approach to mental health treatment.
For some people, conventional mental-health treatments have not provided sufficient relief. Ketamine has been studied and used off-label in certain psychiatric treatment settings. Understanding its potential role, limitations, and safety considerations begins with a qualified clinical evaluation.
Evaluation first
Suitability is assessed by a qualified clinician before any treatment decision is made.
Understanding the treatment
What is ketamine therapy?
Ketamine is a medication approved by the FDA for anesthetic uses. Its use in treating psychiatric conditions, including depression, is considered off-label.
Research has examined ketamine's potential effects on depressive symptoms, particularly in people who have not responded adequately to previous treatments. However, it is not appropriate for everyone, and individual responses vary.
Understanding the evidence — and its limits — is part of a good evaluation.
Every option deserves a careful look.
A fair question
No.
Is ketamine right for everyone?
A clinician must consider medical and psychiatric history, existing medications, potential risks, and previous treatment experiences before determining whether ketamine should be considered.
What to expect
Understanding the treatment process.
An individualized care pathway generally involves the steps below.
- 1
Initial assessment
A clinician reviews your medical and psychiatric history and previous treatment experiences.
- 2
Discussing benefits & risks
Potential benefits, limitations, and risks are discussed openly and clearly.
- 3
Treatment planning
If appropriate, an individualized care pathway is developed with the clinical team.
- 4
Ongoing follow-up
Care continues with follow-up as your treatment plan moves forward.
A note on specifics. The exact administration method, monitoring requirements, and treatment schedule will be explained by Neurobody's clinical team once the treatment protocol is confirmed.
Questions
Ketamine questions, answered.
Educational answers only — your clinician will guide decisions about your care.
No. Ketamine is FDA-approved for anesthetic uses. Its use in treating depression and other psychiatric conditions is considered off-label, and any such use follows a thorough clinical evaluation.
Spravato (esketamine) is an FDA-approved nasal spray for certain adults with treatment-resistant depression, given in a certified setting with required monitoring. Ketamine is approved as an anesthetic, and its psychiatric use is off-label. A clinician can explain which option, if either, may be appropriate for you.
A clinician reviews your symptoms, medical and mental-health history, current medications, and previous treatments, then discusses which options may be appropriate and answers your questions.
Ketamine can cause side effects and is not appropriate for everyone. Potential risks depend on your medical and psychiatric history and the treatment setting. These are discussed in detail during the evaluation, before any treatment decisions are made.
By carefully considering your medical and psychiatric history, existing medications, potential risks, and previous treatment experiences. Suitability is determined only by a qualified clinician.
Begin with a conversation
Interested in understanding whether ketamine may be an appropriate option?
Speak with the Neurobody team in Atlanta. Every conversation begins with a thorough psychiatric evaluation — not a quick decision.
Request an EvaluationEducational information only. All treatment decisions are made by qualified clinicians.